Imaging tumor thrombus across malignancies: current concepts and the expanding role of PET/computed tomography.
1/5 보강
Tumor thrombus (TT) represents the intravascular extension of the tumor, most commonly seen in renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).
APA
Kumar SA, Jain S, et al. (2026). Imaging tumor thrombus across malignancies: current concepts and the expanding role of PET/computed tomography.. Nuclear medicine communications, 47(3), 267-279. https://doi.org/10.1097/MNM.0000000000002090
MLA
Kumar SA, et al.. "Imaging tumor thrombus across malignancies: current concepts and the expanding role of PET/computed tomography.." Nuclear medicine communications, vol. 47, no. 3, 2026, pp. 267-279.
PMID
41529262 ↗
Abstract 한글 요약
Tumor thrombus (TT) represents the intravascular extension of the tumor, most commonly seen in renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). It is clinically significant with direct implications on staging, prognosis, and therapeutic decision-making. TT is most commonly noted in RCC and HCC, but can also occur in several other malignancies, such as adrenal cortical carcinoma, colorectal carcinoma, pancreatic neuroendocrine tumors, thyroid carcinoma, and testicular carcinoma. Differentiating TT and bland thrombus is crucial. Surgical resection offers survival benefit in select cases, whereas systemic therapies, including immunotherapy and targeted agents, are transforming the management of RCC and HCC with vascular invasion. TT is a marker of aggressive tumor biology that significantly worsens the prognosis. This review highlights current knowledge about the pathogenesis, imaging features, prognostic impact, and therapeutic approaches to TT, with emphasis on the evolving role of nuclear medicine, and provides a narrative review of peer-reviewed literature and available guidelines.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.